Form4insider filings, from the source

SEC Form 4 · accession 0001193805-17-003553

Protara Therapeutics, Inc. · TARA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
DEERFIELD MANAGEMENT CO
Director · Other
Deerfield Mgmt L.P.
10% Owner · Other
DEERFIELD PARTNERS, L.P.
10% Owner · Other
James E Flynn
Director · Other
Period of report
Nov 30, 2017
Accepted (ET)
Dec 4, 2017 · 5:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001359931

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3Nov 30, 2017P110,557$1.75A197,424IThrough Deerfield Partners, L.P.
Common StockF1,F2,F3Nov 30, 2017S110,557$1.75D0IThrough Deerfield International Master Fund, L.P.
Common StockF2,F3holding———149,676IDeerfield Special Situations Fund, L.P.
Common StockF2,F3holding———877,799IDeerfield Private Design Fund III, L.P.

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

Jonathan S. Leff, a partner in Deerfield Management, serves as a director of the Issuer. Jonathan Isler, Attorney-in-Fact: Power of Attorney, which is hereby incorporated by reference to Exhibit 24 to a Form 3 with regard to the Issuer filed with the Securities and Exchange Commission on August 4, 2017 by Deerfield Special Situations Fund, L.P., Deerfield Partners, L.P., Deerfield International Master Fund, L.P., Deerfield Private Design Fund III, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Management Company, L.P., and James E. Flynn.